We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | -0.42% | 117.50 | 115.00 | 120.00 | 117.50 | 117.50 | 117.50 | 4,573 | 08:00:19 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -28.73M | -0.4177 | -2.81 | 80.82M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 08/8/2018 11:34 | Ipost, you are the illiterate one from IIP who cannot string a sentence together without swearing. Still a class act I see with your multi-alias approach. | sapper2476 | |
| 08/8/2018 11:32 | Idp worth a look | milliecusto | |
| 08/8/2018 11:26 | Er. No chance. | charlesjames1 | |
| 08/8/2018 11:23 | 200p today ?? | oldbronze | |
| 08/8/2018 11:11 | all that for a UT of 364 shares! :) | sportbilly1976 | |
| 08/8/2018 11:03 | IDP also blooming | letmepass | |
| 08/8/2018 11:00 | 10.50 to 11 am auction time ignore that spread | sigora | |
| 08/8/2018 10:58 | 135/110 spread?? | sportbilly1976 | |
| 08/8/2018 10:52 | Got out at 132, very overheated | milliecusto | |
| 08/8/2018 10:51 | Double topped time to take a breather | letmepass | |
| 08/8/2018 10:44 | @CUDMORE DO YOU HOMEWORK!! This stock is VERY under valued!!! MM have been playing games and collecting the stock. Know they are moving this up so no one can get in cheap! | jayj4u | |
| 08/8/2018 10:23 | From a good post on lse | milliecusto | |
| 08/8/2018 10:23 | based in Seoul, has been granted a license to develop and commercialise Traumakine® for the treatment of ARDS in Korea. Faron has received an initial signing fee of 750,000 and is entitled to receive additional, development based milestones. In addition, Faron will receive third of Traumakine® profits, representing a double digit royalty on net sales, depending on end user pricing, and has agreed to cover development costs for Traumakine® in Korea. Additionally, Faron will provide European approval material for Pharmbio to obtain market authorisation in Korea and will also supply Traumakine drug product to Pharmbio at an agreed transfer price. | milliecusto | |
| 08/8/2018 10:15 | Pop over to lse to understand the forth coming deal | milliecusto | |
| 08/8/2018 10:06 | Suggest you do some homework first | milliecusto | |
| 08/8/2018 10:06 | Hello Cuddy | lovegod | |
| 08/8/2018 10:05 | PUMP AND DUMP........Be careful!!! | cudmore | |
| 08/8/2018 09:57 | At this rate MM know they will be in BIG trouble!!! Not much stock on the market....hence price keeps going up before the news!!! Hold on guys!!!! £2 by the end of this week! | jayj4u | |
| 08/8/2018 09:34 | Blitzed 100k profit now booooooom | kirk 6 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
